Zero Point Five Therapeutics
Latest round
- Series C
Last raised
- Apr 2025
Total raised
- $12M
Investors
- 2
About Zero Point Five Therapeutics
Based in Maryland, US and founded in 2018, Zero point five therapeutics operates as a biotechnology company that focuses on developing ZP5-9676, a drug used to treat neglected tropical diseases. The company was founded by its CEO Joseph Amprey and CSO Helen Pentikis. In April 2025, Zero Point Five Therapeutics, Inc. The biotechnology company develops a drug to fight against diseases caused by whipworms, tapeworms, and hookworms. It is a single-dose therapy that treats soil-transmitted helminths which include Necator americanus, roundworm, whipworm, etc.
Who invested in Zero Point Five Therapeutics
2 investors across 2 rounds
See all investors in Zero Point Five Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zero Point Five Therapeutics
Who invested in Zero Point Five Therapeutics?
Zero Point Five Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zero Point Five Therapeutics raised?
Zero Point Five Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Zero Point Five Therapeutics last raise money?
Zero Point Five Therapeutics's most recent round on record is a Series C, in Apr 2025.
What does Zero Point Five Therapeutics do?
Based in Maryland, US and founded in 2018, Zero point five therapeutics operates as a biotechnology company that focuses on developing ZP5-9676, a drug used to treat neglected tropical diseases.
Where is Zero Point Five Therapeutics headquartered?
Zero Point Five Therapeutics is headquartered in Baltimore, US.
Which VCs invest in companies like Zero Point Five Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zero Point Five Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Zero Point Five Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.